Publications by authors named "Thomas Willows"

Claim this Profile
A
Apomorphine formulation may influence subcutaneous complications from continuous subcutaneous apomorphine infusion in Parkinson's disease.
Peter Hagell, Arja Höglund, Carina Hellqvist, Eva-Lena Johansson, Berit Löwed, Thomas Willows

J Neurol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Initiation of Levodopa-Carbidopa Intestinal Gel Infusion Using Telemedicine (Video Communication System) Facilitates Efficient and Well-Accepted Home Titration in Patients with Advanced Parkinson's Disease.
Thomas Willows, Nil Dizdar, Dag Nyholm, Håkan Widner, Peter Grenholm

J Parkinsons Dis· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic Variations and mRNA Expression of NRF2 in Parkinson's Disease.
Caroline Ran, Karin Wirdefeldt, Lovisa Brodin, Mehrafarin Ramezani, Marie Westerlund, Thomas Willows

Parkinsons Dis· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strong association between glucocerebrosidase mutations and Parkinson's disease in Sweden.
Caroline Ran, Lovisa Brodin, Lars Forsgren, Marie Westerlund, Mehrafarin Ramezani, Thomas Willows

Neurobiol Aging· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validity and Responsiveness of At-Home Touch Screen Assessments in Advanced Parkinson's Disease.
Mevludin Memedi, Dag Nyholm, Anders Johansson, Sven Pålhagen, Thomas Willows

IEEE J Biomed Health Inform· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The HLA-DRA variation rs3129882 is not associated with Parkinson's disease in Sweden.
Caroline Ran, Thomas Willows, Olof Sydow, Anders Johansson, Peter Söderkvist

Parkinsonism Relat Disord· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CMV-associated encephalitis and antineuronal autoantibodies--a case report.
Xinling Xu, Peter Bergman, Thomas Willows, Charlotte Tammik, Marie Sund

BMC Neurol· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic Screening of the Mitochondrial Rho GTPases MIRO1 and MIRO2 in Parkinson's Disease.
Anna Anvret, Caroline Ran, Marie Westerlund, Olof Sydow, Thomas Willows

Open Neurol J· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of a protective paraoxonase 1 (PON1) polymorphism in Parkinson's disease.
Andrea Carmine Belin, Caroline Ran, Anna Anvret, Silvia Paddock, Marie Westerlund, Thomas Willows

Neurosci Lett· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic studies of the protein kinase AKT1 in Parkinson's disease.
Caroline Ran, Marie Westerlund, Anna Anvret, Thomas Willows, Olof Sydow

Neurosci Lett· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pharmacokinetic-pharmacodynamic model for duodenal levodopa infusion.
Jerker Westin, Dag Nyholm, Sven Pålhagen, Thomas Willows, Torgny Groth

Clin Neuropharmacol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DJ-1 Mutations are Rare in a Swedish Parkinson Cohort.
Anna Anvret, Jeff G Blackinton, Marie Westerlund, Caroline Ran, Olof Sydow, Thomas Willows

Open Neurol J· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Variations of the CAG trinucleotide repeat in DNA polymerase γ (POLG1) is associated with Parkinson's disease in Sweden.
Anna Anvret, Marie Westerlund, Olof Sydow, Thomas Willows, Charlotta Lind

Neurosci Lett· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term 24-hour duodenal infusion of levodopa: outcome and dose requirements.
Dag Nyholm, Rasmus Jansson, Thomas Willows, Ingela Nilsson Remahl

Neurology· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis